Acadian Asset Management LLC Neuronetics, Inc. Transaction History

Acadian Asset Management LLC

$32.5 Billion
Q2 2024

A detailed history of Acadian Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 326,975 shares of STIM stock, worth $245,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares

326,975

Previous 264,347 23.69%

Holding current value

$245,231

Previous $1.26 Million 53.26%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$1.73 - $4.81 $108,346 - $301,240	62,628 Added 23.69%	326,975 $587,000
Q1 2024 May 10, 2024	SELL	$2.68 - $4.8 $91,580 - $164,025	-34,172 Reduced 11.45%	264,347 $1.26 Million
Q4 2023 Feb 13, 2024	SELL	$1.05 - $2.9 $74,534 - $205,856	-70,985 Reduced 19.21%	298,519 $864,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $2.22 $67,237 - $115,710	-52,122 Reduced 12.36%	369,504 $498,000
Q2 2023 Aug 07, 2023	BUY	$2.07 - $2.92 $12,701 - $17,917	6,136 Added 1.48%	421,626 $905,000
Q1 2023 May 11, 2023	BUY	$2.81 - $6.71 $1.05 Million - $2.51 Million	373,782 Added 896.19%	415,490 $1.21 Million
Q4 2022 Feb 14, 2023	BUY	$2.74 - $6.87 $104,180 - $261,211	38,022 Added 1031.52%	41,708 $284,000
Q3 2022 Nov 14, 2022	BUY	$2.35 - $4.66 $8,662 - $17,176	3,686 New	3,686 $11,000
Q4 2021 Feb 10, 2022	SELL	$3.87 - $6.59 $15,077 - $25,674	-3,896 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.22 - $15.54 $24,233 - $60,543	3,896 New	3,896 $25,000
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.61 $32,214 - $59,630	-22,847 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$1.28 - $4.5 $29,244 - $102,811	22,847 New	22,847 $43,000

Others Institutions Holding STIM

# of Institutions

Shares Held

18.3M

Call Options Held

Put Options Held

3.8K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $20.3M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Neuronetics, Inc. Transaction History